TY - JOUR
T1 - The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors
T2 - A qualitative systematic review and thematic synthesis
AU - Peddie, Nicola
AU - Agnew, Sommer
AU - Crawford, Megan
AU - Dixon, Diane
AU - MacPherson, Iain
AU - Fleming, Leanne
N1 - The authors would like to thank the Chief Scientist Office for supporting this research.
Funding Information:
This work was supported by a Chief Scientist Office Catalytic Research Grant ( CGA/19/62 ).
The protocol for this review is available on PROSPERO (CRD42020192481).
PY - 2021/8/1
Y1 - 2021/8/1
N2 - Background: Hormone Therapy (HT) reduces the risk of breast cancer recurrence and mortality in women with breast cancer. Despite these clinical benefits, rates of HT non-adherence and non-persistence are high. Research suggests this may be due to the impact of HT side effects. However, little research has explored the individual contribution of side effects to non-adherence and non-persistence behaviours, thereby hindering the implementation of targeted intervention strategies. Our aim is to review the published literature on breast cancer survivors’ lived experiences of HT side effects and explore how these may be related to non-adherence and non-persistence behaviour. Methods: Electronic searches were conducted from inception to May 2020, utilising Cochrane CENTRAL, Medline, Embase, Web of Science and PsycINFO databases. Searches included a combination of terms related to breast cancer, adherence, hormone therapy and side effects. Results: Sixteen eligible papers were identified, and study quality was high. Data were thematically synthesised into four analytical themes, which encompassed 13 descriptive sub-themes: ‘Daily impact of side-effects’, ‘Role of Health Care Professionals’, ‘Managing HT side-effects’, and ‘Weighing up the pros and cons’. Conclusions: HT side effects significantly impact breast cancer survivor's quality of life. A lack of support from healthcare providers leads to self-management strategies, which negatively affects adherence and persistence behaviour.
AB - Background: Hormone Therapy (HT) reduces the risk of breast cancer recurrence and mortality in women with breast cancer. Despite these clinical benefits, rates of HT non-adherence and non-persistence are high. Research suggests this may be due to the impact of HT side effects. However, little research has explored the individual contribution of side effects to non-adherence and non-persistence behaviours, thereby hindering the implementation of targeted intervention strategies. Our aim is to review the published literature on breast cancer survivors’ lived experiences of HT side effects and explore how these may be related to non-adherence and non-persistence behaviour. Methods: Electronic searches were conducted from inception to May 2020, utilising Cochrane CENTRAL, Medline, Embase, Web of Science and PsycINFO databases. Searches included a combination of terms related to breast cancer, adherence, hormone therapy and side effects. Results: Sixteen eligible papers were identified, and study quality was high. Data were thematically synthesised into four analytical themes, which encompassed 13 descriptive sub-themes: ‘Daily impact of side-effects’, ‘Role of Health Care Professionals’, ‘Managing HT side-effects’, and ‘Weighing up the pros and cons’. Conclusions: HT side effects significantly impact breast cancer survivor's quality of life. A lack of support from healthcare providers leads to self-management strategies, which negatively affects adherence and persistence behaviour.
KW - Adherence
KW - Adjuvant hormone therapy
KW - Aromatase inhibitor
KW - Breast cancer
KW - Endocrine therapy
KW - Persistence
KW - Qualitative
KW - Side effects
KW - Tamoxifen
UR - http://www.scopus.com/inward/record.url?scp=85106531943&partnerID=8YFLogxK
U2 - 10.1016/j.breast.2021.05.005
DO - 10.1016/j.breast.2021.05.005
M3 - Review article
AN - SCOPUS:85106531943
VL - 58
SP - 147
EP - 159
JO - Breast
JF - Breast
SN - 0960-9776
ER -
